Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Osteonecrosis in protease inhibitor-treated patients.
Bonfanti P, Grabbuti A, Carradori S, Pusterla L, Parrazini F, Landonio S, Quirino T; Italian Coordination for the Study of Allergies and HIV Infection. Bonfanti P, et al. Among authors: quirino t. Orthopedics. 2001 Mar;24(3):271-2. doi: 10.3928/0147-7447-20010301-19. Orthopedics. 2001. PMID: 11300292
Predictors of protease inhibitor-associated adverse events.
Bonfanti P, Ricci E, Landonio S, Valsecchi L, Timillero L, Faggion I, Quirino T; CISAI study group. Italian Coordination for the Study of HIV Infection and Allergies. Bonfanti P, et al. Among authors: quirino t. Biomed Pharmacother. 2001 Jul;55(6):321-3. doi: 10.1016/s0753-3322(01)00070-1. Biomed Pharmacother. 2001. PMID: 11478584 Clinical Trial.
Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART.
Landonio S, Quirino T, Bonfanti P, Gabris A, Boccassini L, Gulisano C, Vulpio L, Ricci E, Carrabba M, Vigevani GM. Landonio S, et al. Among authors: quirino t. Biomed Pharmacother. 2004 Nov;58(9):505-8. doi: 10.1016/j.biopha.2004.08.019. Biomed Pharmacother. 2004. PMID: 15511607
An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir.
Bonfanti P, Martinelli C, Ricci E, Carradori S, Parruti G, Armignacco O, Magnani C, Quirino T; CISAI Group (Italian Coordinators for the Study of Allergies HIV Infection). Bonfanti P, et al. Among authors: quirino t. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):317-20. doi: 10.1097/01.qai.0000164248.56722.3c. J Acquir Immune Defic Syndr. 2005. PMID: 15980692
Metabolic syndrome: a real threat for HIV-positive patients?: Results from the SIMONE study.
Bonfanti P, Ricci E, de Socio G, Zeme D, Carradori S, Penco G, Parruti G, Grosso C, Madeddu G, Vichi F, Bini T, Martinelli C, Melzi S, Quirino T; CISAI Study Group. Bonfanti P, et al. Among authors: quirino t. J Acquir Immune Defic Syndr. 2006 May;42(1):128-31. doi: 10.1097/01.qai.0000219775.20174.2d. J Acquir Immune Defic Syndr. 2006. PMID: 16763502 No abstract available.
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].
Madeddu G, Quirino T, Carradori S, Ricci E, Grosso C, Penco G, De Socio G, Rossella E, Palvarini L, Marconi P, Melzi S, Mura MS, Bonfanti P; Gruppo CISAI. Madeddu G, et al. Among authors: quirino t. Infez Med. 2006 Sep;14(3):125-34. Infez Med. 2006. PMID: 17127826 Free article. Review. Italian.
173 results